Xuexin Yu

1.3k citations
30 papers · 952 indexed · 1 hit paper · h-index 15
Topics
MicroRNA in disease regulation (8 papers)RNA modifications and cancer (8 papers)Cancer-related molecular mechanisms research (7 papers)
Partner nations
ChinaUnited StatesIndia

In The Last Decade

Xuexin Yu

30 papers receiving 937 citations

Hit Papers

Lactate increases stemness of CD8 + T cells to augment an...2022202620232024202250100150200250

Peers

Xuexin Yu
Comparison fields: 5 of 95
  • Molecular Biology 645
  • Cancer Research 527
  • Immunology 177
  • Oncology 137
  • Pulmonary and Respiratory Medicine 79
Replace Zhenzi Peng with:
Zhenzi Peng China
Hao Zhuang China
Mahmoud M. Ibrahim Germany
Wen‐Ling Chan Taiwan
Yiwen Xia China
Gina M. Sizemore United States
Yi Liao China
Young‐Kyoung Lee South Korea
Xuexin Yu relative to Zhenzi Peng China Zhenzi Peng's profile →
Citations per field
00.5×10×15×20×24×
Zhenzi Peng · 1×
Citations per year

Countries citing papers authored by Xuexin Yu

Since Specialization
Citations

This map shows the geographic impact of Xuexin Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuexin Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuexin Yu more than expected).

Fields of papers citing papers by Xuexin Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuexin Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuexin Yu. The network helps show where Xuexin Yu may publish in the future.

Co-authorship network of co-authors of Xuexin Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Xuexin Yu. A scholar is included among the top collaborators of Xuexin Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuexin Yu. Xuexin Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 5
2 5
3 54
4
Lactate increases stemness of CD8 + T cells to augment anti-tumor immunitybreakdown →
254
5 4
6 1
7 20
8 2
9 31
10 3
11 5
12 10
13 20
14 27
15 6
16 10
17 19
18 9
19 52
20 33

About Xuexin Yu

Xuexin Yu is a scholar working on Cancer Research, Molecular Biology and Oncology, having authored 30 papers that have together received 952 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (8 papers), RNA modifications and cancer (8 papers) and Cancer-related molecular mechanisms research (7 papers). The work is most often cited by research in Cancer Research (527 citations), Molecular Biology (645 citations) and Immunology (177 citations). Xuexin Yu has collaborated with scholars based in China, United States and India. Frequent co-authors include Wei Jiang, Shuyuan Wang, Enyu Dai, Fanlin Meng, Xia Li, Bo Li, Yan Zhang, Xinyi Liu, Zhida Liu and Baran D. Sumer. Their work appears in journals such as Nature Communications, Bioinformatics and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026